The present invention provides novel ureas containing N-aryl or N-heteroaryl substituted heterocycles and analogues thereof, which are selective inhibitors of the human P2Y.sub.1 receptor. The invention also provides for various pharmaceutical compositions of the same and methods for treating diseases responsive to modulation of P2Y.sub.1 receptor activity.

 
Web www.patentalert.com

< RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (siNA)

< Oligoribonucleotides for the treatment of irritative or inflammatory skin symptoms through RNA interference

> Compositions and methods for inhibiting bone resorption

> Methods and compositions for the non-surgical removal of fat
~ 00222